When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Infecções oportunistas relacionadas ao vírus da imunodeficiência humana (HIV)

Última revisión: 18 Jan 2026
Última actualización: 11 Sep 2025

Resumen

Definition

History and exam

Key diagnostic factors

  • ausência de terapia antirretroviral (TAR) ou falha da TAR
  • febre
  • cefaleia e estado mental alterado
  • dispneia ou tosse
  • dor abdominal, diarreia, perda de peso
  • disfagia
  • linfadenopatia
  • moscas volantes, dor ocular e cegueira
  • hemorragia ocular
  • alterações na mucosa
Full details

Other diagnostic factors

  • hepatoesplenomegalia
  • dessaturação de oxigênio induzida por exercício
  • visão turva e fotofobia
  • papiledema
  • meningismo, achados neurológicos focais
  • dor e fraqueza
  • dor nos ossos e nas articulações
  • lesões cutâneas
Full details

Risk factors

  • soroconversão pós-HIV com qualquer contagem de CD4
  • Contagem de CD4 abaixo de 250 células/microlitro
  • Contagem de CD4 abaixo de 200 células/microlitro
  • Contagem de CD4 abaixo de 150 células/microlitro
  • Contagem de CD4 abaixo de 100 células/microlitro
  • Contagem de CD4 abaixo de 50 células/microlitro
  • ausência de terapia antirretroviral (TAR) ou falha da TAR
  • homens que fazem sexo com homens (HSH)
  • raça negra ou hispânicos
  • uso de substâncias por via intravenosa
  • fatores socioeconômicos (pobreza, aglomerações, desabrigados, desnutrição)
  • inalação de poeira em áreas endêmicas de Coccidioides e Histoplasma
Full details

Diagnostic tests

1st tests to order

  • contagem de células CD4
  • coloração e cultura do escarro
  • hemoculturas
  • adenosina desaminase
  • sorologia para Toxoplasma gondii
  • Sorologia para Coccidioides
  • antígeno polissacarídeo criptocócico
  • Antígeno de Histoplasma capsulatum
  • Cultura de Histoplasma capsulatum
  • Hemograma completo
  • testes da função hepática
  • lactato desidrogenase (LDH)
  • gasometria arterial
  • radiografia torácica
  • tomografia computadorizada (TC) de crânio
Full details

Tests to consider

  • teste de amplificação de ácido nucleico de tuberculose (TB)
  • ensaio de lipoarabinomanano de fluxo lateral na urina (LF-LAM)
  • lavagem broncoalveolar (LBA)
  • raspagens orofaríngeas (solução de hidróxido de potássio [KOH]) e cultura
  • Análise do líquido cefalorraquidiano (LCR)
  • reação em cadeia da polimerase: líquido cefalorraquidiano (LCR), líquido de lavagem broncoalveolar (LBA) e amostra de humor vítreo e aquoso para Toxoplasma gondii
  • aspirado e cultura da medula óssea
  • aspirado ou biópsia de linfonodos
  • biópsia tecidual
  • biópsia do cérebro
  • tomografia computadorizada (TC) abdominal
  • TC de alta resolução (TCAR) do tórax
  • reação em cadeia da polimerase para pneumonia por Pneumocystis jirovecii (PPC)
  • beta-D-glicano
  • ressonância nuclear magnética (RNM) cranioencefálica
  • tomografia computadorizada por emissão de fóton único com tálio e PET
  • endoscopia digestiva alta e colonoscopia
  • teste de antígeno coccidioidal
  • reação em cadeia da polimerase para Coccidioides
  • reação em cadeia da polimerase para Histoplasma
Full details

Treatment algorithm

ACUTE

Infecção por Mycobacterium tuberculosis

complexo M avium disseminado

Pneumonia por Pneumocystis jirovecii

Encefalite por Toxoplasma gondii

meningite criptocócica

citomegalovírus

candidíase mucocutânea

coccidioidomicose

Histoplasmose disseminada

Contributors

Authors

Jake Scott, MD

Clinical Associate Professor

Infectious Diseases and Geographic Medicine

Stanford University School of Medicine

Antimicrobial Stewardship Program Medical Director

Stanford Health Care Tri-Valley

Pleasanton

CA

Disclosures

JS declares that he has no competing interests.

Acknowledgements

Dr Jake Scott would like to gratefully acknowledge Dr, Ruth Byrne, Dr Mark Nelson, and Dr Irene Alexandraki, previous contributors to this topic.

Disclosures

RB, MN, and IA declare that they have no competing interests.

Peer reviewers

Thomas B. Campbell, MD

Professor of Medicine

University of Colorado Anschutz

Aurora

CO

Disclosures

Unpaid member of the US DHHS Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents With HIV and the National Comprehensive Cancer Network Guidelines for Cancer in People with HIV and Kaposi Sarcoma.

Ellen Kitchell, MD, FIDSA, AAHIVM-S

Associate Professor

University of Texas Southwestern

Dallas

TX

Disclosures

EK declares that she has no competing interests.

Colm O'Mahony, MD, FRCP, BSc, DIPVen

Consultant in Sexual Health

Department of Sexual Health

Countess of Chester Hospital NHS Foundation Trust

Chester

UK

Disclosures

CO declares that he has no competing interests.

Nicola Steedman, MRCP, DipGUM, DipHIV

Consultant Physician in Sexual Health and HIV

Department of Sexual Health

Countess of Chester Hospital NHS Foundation Trust

Chester

UK

Disclosures

NS declares that she has no competing interests.

William R. Rodriguez, MD

Assistant Professor of Medicine

Massachusetts General Hospital

Charlestown

MA

Disclosures

WRR declares that he has no competing interests.

Peer reviewer acknowledgements

BMJ Best Practice topics are updated on a rolling basis in line with developments in evidence and guidance. The peer reviewers listed here have reviewed the content at least once during the history of the topic.

Disclosures

Peer reviewer affiliations and disclosures pertain to the time of the review.

References

Our in-house evidence and editorial teams collaborate with international expert contributors and peer reviewers to ensure that we provide access to the most clinically relevant information possible.

Key articles

National Institutes of Health, Centers for Disease Control and Prevention, HIV Medicine Association, and Infectious Diseases Society of America. Panel on Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV. 2025 [internet publication].Full text

World Health Organization. Guidelines for diagnosing, preventing and managing cryptococcal disease among adults, adolescents and children living with HIV. Jun 2022 [internet publication].Full text

Griffith DE, Aksamit T, Brown-Elliott BA, et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med. 2007 Feb 15;175(4):367-416.Full text  Abstract

Wheat LJ, Freifeld AG, Kleiman MB, et al. Clinical practice guidelines for the management of patients with histoplasmosis: 2007 update by the Infectious Diseases Society of America. Clin Infect Dis. 2007 Oct 1;45(7):807-25.Full text  Abstract

Chang CC, Harrison TS, Bicanic TA, et al. Global guideline for the diagnosis and management of cryptococcosis: an initiative of the ECMM and ISHAM in cooperation with the ASM. Lancet Infect Dis. 2024 Aug;24(8):e495-512.Full text  Abstract

Pappas PG, Kauffman CA, Andes DR, et al. Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis. 2016 Feb 15;62(4):e1-50.Full text  Abstract

Reference articles

A full list of sources referenced in this topic is available to users with access to all of BMJ Best Practice.
  • Differentials

    • Pneumonia
    • Diarreia
    • Meningite
    More Differentials
  • Guidelines

    • Guidelines for the prevention and treatment of opportunistic infections in adults and adolescents with HIV
    • Antiretroviral drugs for treatment and prevention of HIV in adults: 2024 recommendations of the International Antiviral Society–USA panel
    More Guidelines
  • Patient information

    Toxoplasmose na gravidez: quais são as opções de tratamento?

    Tuberculose

    More Patient information
  • padlock-lockedLog in or subscribe to access all of BMJ Best Practice

Use of this content is subject to our disclaimer